Publicacions (17) Publicacions en què ha participat algun/a investigador/a

2007

  1. A network analysis of the human T-cell activation gene network identifies Jagged1 as a therapeutic target for autoimmune diseases

    PLoS ONE, Vol. 2, Núm. 11

  2. Absence of surface expression of CD137 (4-1BB) on Myeloid-derived suppressor cells

    Inmunologia, Vol. 26, Núm. 3, pp. 121-126

  3. Anti-idiotype antibodies in cancer treatment

    Oncogene, Vol. 26, Núm. 25, pp. 3594-3602

  4. Antitumor T-cell wars: Do CD4s outwit CD8s?

    Blood

  5. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8+ T cells

    Clinical and Experimental Immunology, Vol. 149, Núm. 1, pp. 87-96

  6. Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer

    Expert Opinion on Biological Therapy, Vol. 7, Núm. 5, pp. 599-615

  7. Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor

    Journal of Biological Chemistry, Vol. 282, Núm. 10, pp. 7405-7415

  8. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions

    Journal of Investigative Dermatology, Vol. 127, Núm. 7, pp. 1673-1680

  9. Immunostimulatory monoclonal antibodies for cancer therapy

    Nature Reviews Cancer, Vol. 7, Núm. 2, pp. 95-106

  10. Immunotherapy and immunoescape in colorectal cancer

    World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5822-5831

  11. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells

    Blood, Vol. 109, Núm. 6, pp. 2634-2642

  12. La terapia celular antitumoral

    Gastroenterologia y Hepatologia Continuada

  13. Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature

    Biochemical and Biophysical Research Communications, Vol. 364, Núm. 1, pp. 92-99

  14. Nuevos tratamientos para el carcinoma renal

    Anales del sistema sanitario de Navarra, Vol. 30, Núm. 3, pp. 393-403

  15. Parvovirus B19 acute infection and a reactivation of cytomegalovirus and herpesvirus 6 in a chronic myeloid leukemia patient during treatment with dasatinib (BMS-354825)

    Leukemia and Lymphoma, Vol. 48, Núm. 12, pp. 2461-2464

  16. The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ

    International Journal of Cancer, Vol. 121, Núm. 6, pp. 1282-1295

  17. The many faces of regulatory T cells

    Inmunologia, Vol. 26, Núm. 1, pp. 29-41